A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes


Human African trypanosomiasis, endemic to sub-Saharan Africa, is invariably fatal if untreated. Its causative agent is the protozoan parasite Trypanosoma brucei. Eflornithine is used as a first line treatment for human African trypanosomiasis, but there is a risk that resistance could thwart its use, even when used in combination therapy with nifurtimox. Eflornithine resistant trypanosomes were selected in vitro and subjected to biochemical and genetic analysis. The resistance phenotype was verified in vivo. Here we report the molecular basis of resistance. While the drug's target, ornithine decarboxylase, was unaltered in resistant cells and changes to levels of metabolites in the targeted polyamine pathway were not apparent, the accumulation of eflornithine was shown to be diminished in resistant lines. An amino acid transporter gene, TbAAT6 (Tb927.8.5450), was found to be deleted in two lines independently selected for resistance. Ablating expression of this gene in wildtype cells using RNA interference led to acquisition of resistance while expression of an ectopic copy of the gene introduced into the resistant deletion lines restored sensitivity, confirming the role of TbAAT6 in eflornithine action. Eflornithine resistance is easy to select through loss of a putative amino acid transporter, TbAAT6. The loss of this transporter will be easily identified in the field using a simple PCR test, enabling more appropriate chemotherapy to be administered.


Vyšlo v časopise: A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001204
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001204

Souhrn

Human African trypanosomiasis, endemic to sub-Saharan Africa, is invariably fatal if untreated. Its causative agent is the protozoan parasite Trypanosoma brucei. Eflornithine is used as a first line treatment for human African trypanosomiasis, but there is a risk that resistance could thwart its use, even when used in combination therapy with nifurtimox. Eflornithine resistant trypanosomes were selected in vitro and subjected to biochemical and genetic analysis. The resistance phenotype was verified in vivo. Here we report the molecular basis of resistance. While the drug's target, ornithine decarboxylase, was unaltered in resistant cells and changes to levels of metabolites in the targeted polyamine pathway were not apparent, the accumulation of eflornithine was shown to be diminished in resistant lines. An amino acid transporter gene, TbAAT6 (Tb927.8.5450), was found to be deleted in two lines independently selected for resistance. Ablating expression of this gene in wildtype cells using RNA interference led to acquisition of resistance while expression of an ectopic copy of the gene introduced into the resistant deletion lines restored sensitivity, confirming the role of TbAAT6 in eflornithine action. Eflornithine resistance is easy to select through loss of a putative amino acid transporter, TbAAT6. The loss of this transporter will be easily identified in the field using a simple PCR test, enabling more appropriate chemotherapy to be administered.


Zdroje

1. BrunR

BlumJ

ChappuisF

BurriC

2010 Human African trypanosomiasis. Lancet 375 148 159

2. BarrettMP

BoykinDW

BrunR

TidwellRR

2007 Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. British Jounal of Pharmacology 152 1155 1171

3. PriottoG

KasparianS

MutomboW

NgouamaD

GhorashianS

2009 Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 374 56 64

4. OpigoJ

WoodrowC

2009 NECT trial: more than a small victory over sleeping sickness. Lancet 374 7 9

5. BacchiCJ

GarofaloJ

MockenhauptD

McCannPP

DiekemaKA

1983 In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei. Molecular and Biochemical Parasitology 7 209 225

6. PhillipsMA

CoffinoP

WangCC

1987 Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei - implications for enzyme turnover and selective difluoromethylornithine inhibition. Journal of Biological Chemistry 262 8721 8727

7. FairlambAH

HendersonGB

BacchiCJ

CeramiA

1987 In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Molecular and Biochemical Parasitology 24 185 191

8. YarlettN

BacchiCJ

1988 Effect of dl-alpha-difluoromethylornithine on methionine cycle intermediates in Trypanosoma brucei brucei. Molecular and Biochemical Parasitology 27 1 10

9. XiaoY

McCloskeyDE

PhillipsMA

2009 RNA interference-mediated silencing of ornithine decarboxylase and spermidine synthase genes in Trypanosoma brucei provides insight into regulation of polyamine biosynthesis. Eukaryotic Cell 8 747 755

10. BitontiAJ

BacchiCJ

McCannPP

SjoerdsmaA

1986 Uptake of alpha-difluoromethylornithine by Trypanosoma brucei brucei. Biochemical Pharmacology 35 351 354

11. PhillipsMA

WangCC

1987 A Trypanosoma brucei mutant resistant to alpha-difluoromethylornithine. Molecular and Biochemical Parasitology 22 9 17

12. BellofattoV

FairlambAH

HendersonGB

CrossGA

1987 Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei. Molecular and Biochemical Parasitology 25 227 238

13. CarterNS

FairlambAH

1993 Arsenical resistant trypanosomes lack an unusual adenosine transporter. Nature 361 173 176

14. StewartML

KrishnaS

BurchmoreRJ

BrunR

De KoningHP

2005 Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test. Lancet 366 486 487

15. MatovuE

GeiserF

SchneiderV

MaserP

EnyaruJC

2001 Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy. Molecular and Biochemical Parasitology 117 73 81

16. BarrettMP

FairlambAH

1999 The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitology Today 15 136 140

17. SnyderC

CholletJ

Santo-TomasJ

ScheurerC

WittlinS

2007 In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models. Experimental Parasitology 115 296 300

18. FarooqU

MahajanRC

2004 Drug resistance in malaria. Journal of Vector Borne Diseases 41 45 53

19. BacchiCJ

1993 Resistance to clinical drugs in African trypanosomes. Parasitol Today 9 190 193

20. BridgesDJ

GouldMK

NerimaB

MaserP

BurchmoreRJS

2007 Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes. Molecular Pharmacology 71 1098 1108

21. LanteriCA

StewartML

BrockJM

AlibuVP

MeshnickSR

2006 Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance. Molecular Pharmacology 70 1585 1592

22. JacksonAP

2007 Origins of amino acid transporter loci in trypanosomatid parasites. BMC Evolutionary Biology 7 26

23. AlsfordS

HornD

2008 Single-locus targeting constructs for reliable regulated RNAi and transgene expression in Trypanosoma brucei. Molecular and Biochemical Parasitology 161 76 79

24. BiebingerS

WirtzLE

LorenzP

ClaytonC

1997 Vectors for inducible expression of toxic gene products in bloodstream and procyclic Trypanosoma brucei. Molecular and Biochemical Parasitology 85 99 112

25. Shaked-MishanP

Suter-GrotemeyerM

Yoel-AlmagorT

HollandN

ZilbersteinD

2006 A novel high-affinity arginine transporter from the human parasitic protozoan Leishmania donovani. Mol Microbiol 60 30 38

26. CanepaGE

SilberAM

BouvierLA

PereiraCA

2004 Biochemical characterization of a low-affinity arginine permease from the parasite Trypanosoma cruzi. FEMS Microbiol Lett 236 79 84

27. HasneMP

UllmanB

2005 Identification and characterization of a polyamine permease from the protozoan parasite Leishmania major. J Biol Chem 280 15188 15194

28. HasneMP

CoppensI

SoysaR

UllmanB

2010 A high-affinity putrescine-cadaverine transporter from Trypanosoma cruzi. Mol Microbiol 76 78 91

29. BacchiCJ

GarofaloJ

CiminelliM

RattendiD

GoldbergB

1993 Resistance to dl-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense - role of S-adenosylmethionine. Biochemical Pharmacology 46 471 481

30. BacchiCJ

NathanHC

LivingstonT

ValladaresG

SaricM

1990 Differential susceptibility to dl-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrobial Agents and Chemotherapy 34 1183 1188

31. BurkardGS

JutziP

RoditiI

2010 Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters. Mol Biochem Parasitol

32. SokolovaAY

WyllieS

PattersonS

OzaSL

ReadKD

2010 Cross-resistance to nitro-drugs and implications for the treatment of human African trypanosomiasis. Antimicrobial Agents and Chemotherapy

33. JanssensPG

De MuynckA

1977 Clinical trials with “nifurtimox” in African trypanosomiasis. Annales de la Société belge de médecine tropicale 57 475 480

34. HirumiH

DoyleJJ

HirumiK

1977 Cultivation of bloodstream Trypanosoma brucei. Bulletin of the World Health Organization 55 405 409

35. RazB

ItenM

Grether-BuhlerY

KaminskyR

BrunR

1997 The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Tropica 68 139 147

36. SambrookJ

RussellDW

2001 Preparation and Analysis of Eukaryotic Genomic DNA. Molecular cloning New York Cold Spring Harbor Laboratory Press 6.39 6.58

37. KamlehA

BarrettMP

WildridgeD

BurchmoreRJ

ScheltemaRA

2008 Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules. Rapid Communications in Mass Spectrometry 22 1912 1918

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa